PHYSIOLOGICAL FUNCTIONS 
OF THE LIVER 
Varun kumar Varshney 
Department of Anaesthesiology & critical Care 
JAWAHARLAL NEHRU MEDICAL 
COLLEGE,ALIGARH
• Liver is the largest internal organ & largest gland in 
the human body. 
• Liver is at the epicenter of intermediary metabolism. 
• It performs versatile & massive biochemical pathways. 
• It destroys bacteria, inactivate antigens, detoxify harmful 
chemicals. 
• Thus multiple & diverse functions of liver have an impact 
on every tissue in the body.
Physiological functions of liver 
• Intermediary metabolism 
a. Carbohydrate metabolism 
b. Lipid metabolism 
c. Bile metabolsim and entero- hepatic circulation 
d. Protein metabolism 
• Coagulation 
• Heme metabolism 
• Bilirubin metabolism 
• Xenobiotics metabolism 
• Storage 
• Endocrine functions 
• Immune & inflammatory response 
• Blood reservoir
Carbohydrate metabolism 
• Liver is an important homeostatic regulator of blood 
glucose. 
• It can either produce glucose or store glucose 
• In fed state- polymerize glucose to glycogen 
• In unfed state- depolymerize glycogen to glucose 
• Glucose → hepatocytes → glycogen 
↑ →glucose 
L a c t a t e 
Glycerol 
aminoacids
Carbohydrate metabolism 
• Glycogen metabolism 
• Regulation – 2 rate limiting enzymes 
1. Glycogen synthase- synthesis of glycogen from monomers of 
UDP glucose. 
2. Glycogen phosphorylase- clevage of glycogen to glucose-1- 
phosphate.
Carbohydrate metabolism 
Gluconeogenesis 
• Liver glycogen stores depleted - hepatic gluconeogenesis 
to replenish blood glucose. 
• Substrates- 
- lactate 
- glycerol from hydrolysis of triglycerides 
- gluconeogenic amino acid , alanine , glutamine
• Blood glucose regulation within a narrow limit (70-100 mg/dl)  
not affected in liver disease due to large reserve of hepatic 
function 
 Effects of anaesthesia on carbohydrate metabolism 
• Halothane 
 ¯ release of insulin 
 ­ rate of glycogenolysis 
– Inhibition of gluconeogenic response 
• Isoflurane 
– Impaired insulin secretion
Lipid Metabolism 
 b Oxidation of fatty acids 
• Fatty acids derived from plasma 
¯ 
• Enter into mitochondria 
¯ 
 b oxidation: fatty acids  AcetylCoA  citric acid cycle 
• Regulators 
- Glucagon - activates 
- Insulin - inhibits
• Synthesis of lipoproteins 
• One of the major functions of the liver 
• Major classes 
– VLDL 
– LDL 
– HDL
• VLDL 
• Acute or chronic liver disease – ability to produce 
VLDL is markedly compromised 
• Liver VLDLs are associated with an important class 
of proteins, the apo B protein 
• Apo B100 - important for hepatic secretion of VLDL. 
• Decreased in ABETALIPOPROTEINEMIA 
• LDLs and HDLs 
• Liver produces them in a small amount
• Production of ketone bodies 
• Most organs except the liver- use ketone bodies as fuel 
• Ketone bodies – acetoacetic acid, acetone, 
b hydroxybutyrate 
• Their formation by the liver is normal and physiologically important, 
e.g. 
– Fasting  rapid depletion of glycogen stores in the liver  
shortage of substrates for citric acid cycle 
– AcetylCoA formed from b oxidation  ketone bodies 
• Ketosis - ­ conc. of ketone bodies in blood 
– Starvation 
– DM 
– After high fat diet
• Synthesis of cholesterol 
• Important role in cholesterol homeostasis 
• Liver cholesterol has both exogenous and endogenous source 
Uses of hepatic cholesterol 
• Formation of bile acids- conjugated with other substances to form cholic 
acid. 
• Synthesis of VLDLs
Bile metabolism  enterohepatic circulation 
• Bile salts are end products of cholesterol synthesis 
• Daily production – 600- 800 ml/d 
• Functions- 
- activate lipase 
- promote micelle formation 
- intestinal uptake of fat soluble vitamins, cholesterol 
 lipids 
- facilitate excretion of xenobiotics, lipophillic 
substances, bilirubin, amphipathic steroid hormone 
derivative
• Bile salts undergo enterohepatic circulation (20-30 times/day) 
intrahepatic bile duct 
↓ 
common hepatic duct 
cystic duct CBD 
↓ ↓ 
gall bladder small intestine ( terminal ileum) 
• Clinical implication 
– Opioids can induce spasm of bile duct  spinter of oddi 
– Reversed by – glucagon, opioid antagonists ( naloxone), 
smooth muscle relaxant (NTG), antimuscarinic 
drugs( atropine), volatile anaesthetics.
Protein and amino acid metabolism 
• Deamination of amino acids 
– Required before they can be used for energy or before they can be 
converted into carbohydrates or fats 
• Formation of urea for removal of ammonia from the body fluids 
• Production of proteins and peptides.
Krebs- Hanseleit cycle 
 Major pathway for removing NH3  
other nitrogenous wastes from body 
 Captures nitrogen in form of urea. 
 Failing liver- BUN remain low 
- ammonia 
accumulates 
in liver 
↓ 
Hepatic encephalopathy
Proteins  peptides 
Albumin 
• Most abundant protein 
• Normal plasma conc- 3 - 5 g% 
• Daily production -12-15 g/d 
• Plasma half life – 15-20 days 
• Functions – 
• maintains plasma oncotic pressure (80% by albumin) 
• binds ions, bilirubin, hormones  drugs 
• Hypoalbuminemia – ¯ Colloid oncotic pressure  edema
ᾳ- feto protein 
• Resembles albumin genetically  functionally 
• Formation sites- yolksac, hepatocytes, enterocytes 
• Fetal  neonatal life- major determinant of plasma oncotic 
pressure 
• 1 year of age- albumin largely replaces AFP 
• ↑ ↑ AFP- HCC
Fibrinogen 
• Synthesized exclusively by hepatocytes 
• Plasma fibrinogen – 100-700 mg/dl 
• Functions – polymerizes into long fibrin threads by the action of 
thrombin  formation of clot
• Haptoglobins 
– Forms stable complexes with free Hb  prevents loss of iron through 
urinary excretion, protects kidney from damage 
• Ceruloplasmin – binds with copper and helps in its transport and 
storage 
• Wilson’s disease 
– Deficiency of ceruloplasmin  free Cu2+ ­ in circulation  deposited in 
brain and liver
Coagulation 
• Synthesize most of the procoagulants except-a. 
factor III ( tissue thromboplastin) 
b. Factor IV ( calcium) 
c. Factor VIII ( von Willebrand factor ) 
• Produce protein regulators of coagulation  fibrinolytic 
pathways 
– Protein C, protein S ( protein C – inactivate F VIIIa- Va complex) 
– protein Z ( degradation of Factor Xa ) 
– plasminogen activator inhibitor (PAI) ( inhibits tissue plasminogen 
activators to convert plasminogen to plasmin ) 
– antithrombin III
Liver as a Storage Organ 
• Vitamin A 
• Important role in the uptake, storage and maintenance of vitamin A 
levels by mobilizing its vitamin A store 
• Vitamin K 
• Vitamin K dependent factors II, VII, IX, X 
• Absorption of Vit K depends on normal fat absorption: any mal-absorption 
of lipid  vitamin K deficiency 
• Storage in liver- limited  hypoprothrombinemia can develop within a 
few weeks. 
• Treatment – 
• FFP 
• Antidote- parenteral vit K
Vitamin K cofactor  ỳ- carboxylation 
– Factor II, VII., IX, X , protein C  S- undergo Vit K 
dependent post translational modifications 
– Enables procoagulants to form complexes with 
calcium or other divalent cations for participation in 
the clotting cascade. 
Clinical implication 
Warfarin inhibits vit K epoxide reductase 
↓ 
traps Vit K in epoxide form 
↓ 
Inhibits y- carboxylation 
T/T- Enteral / parenteral Vit K.
Storage  Homeostasis of Iron 
• Major site of synthesis of proteins (Transferrin, Ferritin) involved in iron 
transport  metabolism. 
Heme metabolism 
Clinical implication 
• Porphyrias 
• Acute Intermittent Porphyria – commonest 
– Defects in the heme pathway- accumulation of porphyrinogens 
– Trigger substances- barbiturates, sex hormones, glucocorticoides, 
cigarette smoke, CYP inducers.
Bilirubin 
Metabolism
Plasma 
Fragile RBCs 
RE System 
unconjugated bilirubin (protein – bound) 
Liver 
Liver 
BILIRUBIN METABOLISM 
Kidneys 
Urobilinogen 
Conjugated bilirubin Absorbed 
Bacterial 
action 
Urobilinogen 
Stercobilinogen 
Stercobilin 
Oxidation 
Intestinal Contents 
Urobilinogen 
Urobilin 
Oxidation 
Urine
Metabolism of Drugs (Xenobiotics) 
Phase-I reactions 
• Alter the parent drug by inserting or unmasking a polar group 
• Converts drugs to more polar compounds 
• Reactions – oxidations, reduction, hydrolysis 
• Cytochrome P450 – substrate binding site, located in the 
endoplasmic reticulum 
• Drugs– barbiturates, benzodiazepines, halogenated volatile 
anaesthetics, pethidine etc.
• Phase-II reactions 
• Creates conjugates of parent compound or its metabolite with 
endogenous hydrophilic substrate 
Reactions 
• Glucoronidation 
• Sulphation 
• Methylation 
• Acetylation 
Glucoronidation 
• Most common type 
• Hepatic microsomal enzyme, UDPglucuronyl transferase mediates the 
transfer of glucoronic acid from UDP glucuronic acid to the functional 
group on the xenobiotics
• Drug handled by phase-II – morphine, propofol, thiopentone 
(initially oxidized subsequently conjugated) 
Phase-I reaction enzymes – more susceptible to destruction in 
cirrhosis 
Phase-II reactions enzymes – more resistant, function even in 
advanced liver disease 
Phase-III reactions 
• Involves ATP-binding cassette transport proteins (ABC) 
• These proteins use the energy of ATP hydrolysis to drive molecular 
transport 
• Dysfunction of ABC proteins hinders flow of bile  predisposing to 
drug accumulation and cholestatic liver injury
Microsomal enzyme induction 
• Anticonvulsants, rifampicin, isoniazid, glucocorticoids, chronic 
alcohol consumption 
Consequences of enzyme induction 
 ¯ duration of action of drugs that are inactivated by metabolism 
 ­ intensity of action of drugs that are activated by metabolism
Endocrine functions 
• Liver can modify or amplify hormone action 
• Metabolic conversion of Vitamin D to form 25(OH)D 
• 25(OH)D  1,25(OH)2D in kidney 
• Peripheral conversion of T4 to T3 
Pseudocholinesterase 
• Hydrolysis of succinylcholine 
• Plasma t½ - 14 days 
• Severe liver disease  ­ duration of action of succinylcholine
• Insulin-like growth factors or somatomedins – growth hormone like 
action 
• Important role in cartilage function by promoting uptake of sulphate 
and synthesis of collagen 
Removes circulating hormones 
• Insulin, glucagon, growth hormone, gastrointestinal hormones, e.g. 
gastrin
• Blood reservoir 
– Liver is an expandable organ 
– 10 -15 % of total blood volume can be sequestered and quickly 
released after sympathetic stimulation . 
• Immune  inflammatory responses 
– kuffer cells protect against foreign intrutions, degrade toxins, 
process antigens, and phagocytose bacteria. 
– Induce  intensify inflammation by recruiting neutrophils 
– Release proinflammatory mediators
Signs of Liver Disease 
• Jaundice 
• Hepatomegaly 
• Spider Naevi 
• Splenomegaly 
• Scratch Marks 
• Ascites 
• Palmer Erythema 
• Dilated Abdominal 
Veins 
• Peripheral Oedema 
• Finger Clubbing 
• Testicular Atrophy 
• Bruising 
• Gynaecomastia 
• Confusion/Coma
Summary 
• Functions of liver 
I. synthetic 
Plasma protein (albumin) Hypoproteinimea → oedema 
Coagulants Haemorrhagic disorders 
Enzymes Hepatocellular disorders 
Urea / removal of NH3 ↓ bld urea, ↑bld NH3 
II. Metabolic 
Carbohydrate ↓ glycogen – more damage 
↓ bld. Glucose – muscle weakness, personality 
changes, tremors, slurred speech, convulsion, 
coma , death → pre hepatic coma 
Protein metabolism ↑ blood ammonia – aminoaciduria 
lipid metabolism Acc. Of FA in liver → fatty liver →pre hepatic 
hepatitis→ fibrosis→ cirrhosis→ ↑ portal pressure→ 
portal hypertension
III. Bile secretion 
Bile salts  acids steatorrhea 
Conjugation of bilirubin Hepatocellular jaundice 
IV. Miscellaneous 
Vit A, K Deficiency- ↓vit A , K 
Antibacterial action Prevent infections 
Destruction of RBCs Anemia , ↑ bilirubin
THANK YOU

functions-of-the-liver-lft

  • 1.
    PHYSIOLOGICAL FUNCTIONS OFTHE LIVER Varun kumar Varshney Department of Anaesthesiology & critical Care JAWAHARLAL NEHRU MEDICAL COLLEGE,ALIGARH
  • 2.
    • Liver isthe largest internal organ & largest gland in the human body. • Liver is at the epicenter of intermediary metabolism. • It performs versatile & massive biochemical pathways. • It destroys bacteria, inactivate antigens, detoxify harmful chemicals. • Thus multiple & diverse functions of liver have an impact on every tissue in the body.
  • 3.
    Physiological functions ofliver • Intermediary metabolism a. Carbohydrate metabolism b. Lipid metabolism c. Bile metabolsim and entero- hepatic circulation d. Protein metabolism • Coagulation • Heme metabolism • Bilirubin metabolism • Xenobiotics metabolism • Storage • Endocrine functions • Immune & inflammatory response • Blood reservoir
  • 4.
    Carbohydrate metabolism •Liver is an important homeostatic regulator of blood glucose. • It can either produce glucose or store glucose • In fed state- polymerize glucose to glycogen • In unfed state- depolymerize glycogen to glucose • Glucose → hepatocytes → glycogen ↑ →glucose L a c t a t e Glycerol aminoacids
  • 5.
    Carbohydrate metabolism •Glycogen metabolism • Regulation – 2 rate limiting enzymes 1. Glycogen synthase- synthesis of glycogen from monomers of UDP glucose. 2. Glycogen phosphorylase- clevage of glycogen to glucose-1- phosphate.
  • 6.
    Carbohydrate metabolism Gluconeogenesis • Liver glycogen stores depleted - hepatic gluconeogenesis to replenish blood glucose. • Substrates- - lactate - glycerol from hydrolysis of triglycerides - gluconeogenic amino acid , alanine , glutamine
  • 8.
    • Blood glucoseregulation within a narrow limit (70-100 mg/dl)  not affected in liver disease due to large reserve of hepatic function  Effects of anaesthesia on carbohydrate metabolism • Halothane ¯ release of insulin ­ rate of glycogenolysis – Inhibition of gluconeogenic response • Isoflurane – Impaired insulin secretion
  • 9.
    Lipid Metabolism b Oxidation of fatty acids • Fatty acids derived from plasma ¯ • Enter into mitochondria ¯ b oxidation: fatty acids  AcetylCoA  citric acid cycle • Regulators - Glucagon - activates - Insulin - inhibits
  • 10.
    • Synthesis oflipoproteins • One of the major functions of the liver • Major classes – VLDL – LDL – HDL
  • 11.
    • VLDL •Acute or chronic liver disease – ability to produce VLDL is markedly compromised • Liver VLDLs are associated with an important class of proteins, the apo B protein • Apo B100 - important for hepatic secretion of VLDL. • Decreased in ABETALIPOPROTEINEMIA • LDLs and HDLs • Liver produces them in a small amount
  • 12.
    • Production ofketone bodies • Most organs except the liver- use ketone bodies as fuel • Ketone bodies – acetoacetic acid, acetone, b hydroxybutyrate • Their formation by the liver is normal and physiologically important, e.g. – Fasting  rapid depletion of glycogen stores in the liver  shortage of substrates for citric acid cycle – AcetylCoA formed from b oxidation  ketone bodies • Ketosis - ­ conc. of ketone bodies in blood – Starvation – DM – After high fat diet
  • 13.
    • Synthesis ofcholesterol • Important role in cholesterol homeostasis • Liver cholesterol has both exogenous and endogenous source Uses of hepatic cholesterol • Formation of bile acids- conjugated with other substances to form cholic acid. • Synthesis of VLDLs
  • 14.
    Bile metabolism enterohepatic circulation • Bile salts are end products of cholesterol synthesis • Daily production – 600- 800 ml/d • Functions- - activate lipase - promote micelle formation - intestinal uptake of fat soluble vitamins, cholesterol lipids - facilitate excretion of xenobiotics, lipophillic substances, bilirubin, amphipathic steroid hormone derivative
  • 15.
    • Bile saltsundergo enterohepatic circulation (20-30 times/day) intrahepatic bile duct ↓ common hepatic duct cystic duct CBD ↓ ↓ gall bladder small intestine ( terminal ileum) • Clinical implication – Opioids can induce spasm of bile duct spinter of oddi – Reversed by – glucagon, opioid antagonists ( naloxone), smooth muscle relaxant (NTG), antimuscarinic drugs( atropine), volatile anaesthetics.
  • 16.
    Protein and aminoacid metabolism • Deamination of amino acids – Required before they can be used for energy or before they can be converted into carbohydrates or fats • Formation of urea for removal of ammonia from the body fluids • Production of proteins and peptides.
  • 17.
    Krebs- Hanseleit cycle  Major pathway for removing NH3 other nitrogenous wastes from body  Captures nitrogen in form of urea.  Failing liver- BUN remain low - ammonia accumulates in liver ↓ Hepatic encephalopathy
  • 18.
    Proteins peptides Albumin • Most abundant protein • Normal plasma conc- 3 - 5 g% • Daily production -12-15 g/d • Plasma half life – 15-20 days • Functions – • maintains plasma oncotic pressure (80% by albumin) • binds ions, bilirubin, hormones drugs • Hypoalbuminemia – ¯ Colloid oncotic pressure  edema
  • 19.
    ᾳ- feto protein • Resembles albumin genetically functionally • Formation sites- yolksac, hepatocytes, enterocytes • Fetal neonatal life- major determinant of plasma oncotic pressure • 1 year of age- albumin largely replaces AFP • ↑ ↑ AFP- HCC
  • 20.
    Fibrinogen • Synthesizedexclusively by hepatocytes • Plasma fibrinogen – 100-700 mg/dl • Functions – polymerizes into long fibrin threads by the action of thrombin  formation of clot
  • 21.
    • Haptoglobins –Forms stable complexes with free Hb  prevents loss of iron through urinary excretion, protects kidney from damage • Ceruloplasmin – binds with copper and helps in its transport and storage • Wilson’s disease – Deficiency of ceruloplasmin  free Cu2+ ­ in circulation  deposited in brain and liver
  • 22.
    Coagulation • Synthesizemost of the procoagulants except-a. factor III ( tissue thromboplastin) b. Factor IV ( calcium) c. Factor VIII ( von Willebrand factor ) • Produce protein regulators of coagulation fibrinolytic pathways – Protein C, protein S ( protein C – inactivate F VIIIa- Va complex) – protein Z ( degradation of Factor Xa ) – plasminogen activator inhibitor (PAI) ( inhibits tissue plasminogen activators to convert plasminogen to plasmin ) – antithrombin III
  • 23.
    Liver as aStorage Organ • Vitamin A • Important role in the uptake, storage and maintenance of vitamin A levels by mobilizing its vitamin A store • Vitamin K • Vitamin K dependent factors II, VII, IX, X • Absorption of Vit K depends on normal fat absorption: any mal-absorption of lipid  vitamin K deficiency • Storage in liver- limited  hypoprothrombinemia can develop within a few weeks. • Treatment – • FFP • Antidote- parenteral vit K
  • 24.
    Vitamin K cofactor ỳ- carboxylation – Factor II, VII., IX, X , protein C S- undergo Vit K dependent post translational modifications – Enables procoagulants to form complexes with calcium or other divalent cations for participation in the clotting cascade. Clinical implication Warfarin inhibits vit K epoxide reductase ↓ traps Vit K in epoxide form ↓ Inhibits y- carboxylation T/T- Enteral / parenteral Vit K.
  • 25.
    Storage Homeostasisof Iron • Major site of synthesis of proteins (Transferrin, Ferritin) involved in iron transport metabolism. Heme metabolism Clinical implication • Porphyrias • Acute Intermittent Porphyria – commonest – Defects in the heme pathway- accumulation of porphyrinogens – Trigger substances- barbiturates, sex hormones, glucocorticoides, cigarette smoke, CYP inducers.
  • 26.
  • 27.
    Plasma Fragile RBCs RE System unconjugated bilirubin (protein – bound) Liver Liver BILIRUBIN METABOLISM Kidneys Urobilinogen Conjugated bilirubin Absorbed Bacterial action Urobilinogen Stercobilinogen Stercobilin Oxidation Intestinal Contents Urobilinogen Urobilin Oxidation Urine
  • 28.
    Metabolism of Drugs(Xenobiotics) Phase-I reactions • Alter the parent drug by inserting or unmasking a polar group • Converts drugs to more polar compounds • Reactions – oxidations, reduction, hydrolysis • Cytochrome P450 – substrate binding site, located in the endoplasmic reticulum • Drugs– barbiturates, benzodiazepines, halogenated volatile anaesthetics, pethidine etc.
  • 29.
    • Phase-II reactions • Creates conjugates of parent compound or its metabolite with endogenous hydrophilic substrate Reactions • Glucoronidation • Sulphation • Methylation • Acetylation Glucoronidation • Most common type • Hepatic microsomal enzyme, UDPglucuronyl transferase mediates the transfer of glucoronic acid from UDP glucuronic acid to the functional group on the xenobiotics
  • 30.
    • Drug handledby phase-II – morphine, propofol, thiopentone (initially oxidized subsequently conjugated) Phase-I reaction enzymes – more susceptible to destruction in cirrhosis Phase-II reactions enzymes – more resistant, function even in advanced liver disease Phase-III reactions • Involves ATP-binding cassette transport proteins (ABC) • These proteins use the energy of ATP hydrolysis to drive molecular transport • Dysfunction of ABC proteins hinders flow of bile  predisposing to drug accumulation and cholestatic liver injury
  • 31.
    Microsomal enzyme induction • Anticonvulsants, rifampicin, isoniazid, glucocorticoids, chronic alcohol consumption Consequences of enzyme induction  ¯ duration of action of drugs that are inactivated by metabolism  ­ intensity of action of drugs that are activated by metabolism
  • 32.
    Endocrine functions •Liver can modify or amplify hormone action • Metabolic conversion of Vitamin D to form 25(OH)D • 25(OH)D  1,25(OH)2D in kidney • Peripheral conversion of T4 to T3 Pseudocholinesterase • Hydrolysis of succinylcholine • Plasma t½ - 14 days • Severe liver disease  ­ duration of action of succinylcholine
  • 33.
    • Insulin-like growthfactors or somatomedins – growth hormone like action • Important role in cartilage function by promoting uptake of sulphate and synthesis of collagen Removes circulating hormones • Insulin, glucagon, growth hormone, gastrointestinal hormones, e.g. gastrin
  • 34.
    • Blood reservoir – Liver is an expandable organ – 10 -15 % of total blood volume can be sequestered and quickly released after sympathetic stimulation . • Immune inflammatory responses – kuffer cells protect against foreign intrutions, degrade toxins, process antigens, and phagocytose bacteria. – Induce intensify inflammation by recruiting neutrophils – Release proinflammatory mediators
  • 35.
    Signs of LiverDisease • Jaundice • Hepatomegaly • Spider Naevi • Splenomegaly • Scratch Marks • Ascites • Palmer Erythema • Dilated Abdominal Veins • Peripheral Oedema • Finger Clubbing • Testicular Atrophy • Bruising • Gynaecomastia • Confusion/Coma
  • 36.
    Summary • Functionsof liver I. synthetic Plasma protein (albumin) Hypoproteinimea → oedema Coagulants Haemorrhagic disorders Enzymes Hepatocellular disorders Urea / removal of NH3 ↓ bld urea, ↑bld NH3 II. Metabolic Carbohydrate ↓ glycogen – more damage ↓ bld. Glucose – muscle weakness, personality changes, tremors, slurred speech, convulsion, coma , death → pre hepatic coma Protein metabolism ↑ blood ammonia – aminoaciduria lipid metabolism Acc. Of FA in liver → fatty liver →pre hepatic hepatitis→ fibrosis→ cirrhosis→ ↑ portal pressure→ portal hypertension
  • 37.
    III. Bile secretion Bile salts acids steatorrhea Conjugation of bilirubin Hepatocellular jaundice IV. Miscellaneous Vit A, K Deficiency- ↓vit A , K Antibacterial action Prevent infections Destruction of RBCs Anemia , ↑ bilirubin
  • 38.